Literature DB >> 19157553

The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length.

Melissa J Bell1, Jacqueline M Burrows, Rebekah Brennan, John J Miles, Judy Tellam, James McCluskey, Jamie Rossjohn, Rajiv Khanna, Scott R Burrows.   

Abstract

The major ligands presented by MHC class I molecules after natural antigen processing are peptides of eight to ten residues in length, and it is widely accepted that the binding preferences of MHC class I molecules play a dominant role in dictating this classic feature of antigen presentation. In this report, we have reassessed the peptide size specificity of class I human leukocyte antigens (HLAs). By lengthening previously defined T cell epitopes by central amino acid insertion, we demonstrate that the peptide length specificity of some common HLA class I alleles (HLA-B*3501, B*0702 and A*2402) is very broad, and includes peptides of up to 25 residues. These data suggest that the length limitation of naturally processed MHC class I-associated peptides is primarily controlled by peptide availability after antigen processing rather than the binding specificity of MHC class I molecules. Furthermore, the findings provide an explanation for recent reports highlighting that epitopes of >10 amino acids play a minor but significant role in virus-specific immune surveillance by CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19157553     DOI: 10.1016/j.molimm.2008.12.003

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  22 in total

1.  The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.

Authors:  Christina Bade-Döding; Alex Theodossis; Stephanie Gras; Lars Kjer-Nielsen; Britta Eiz-Vesper; Axel Seltsam; Trevor Huyton; Jamie Rossjohn; James McCluskey; Rainer Blasczyk
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

2.  HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.

Authors:  Jodie P Goodridge; Ni Lee; Aura Burian; Chul-Woo Pyo; Scott S Tykodi; Edus H Warren; Cassian Yee; Stanley R Riddell; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

3.  Naturally processed non-canonical HLA-A*02:01 presented peptides.

Authors:  Chopie Hassan; Eric Chabrol; Lorenz Jahn; Michel G D Kester; Arnoud H de Ru; Jan W Drijfhout; Jamie Rossjohn; J H Frederik Falkenburg; Mirjam H M Heemskerk; Stephanie Gras; Peter A van Veelen
Journal:  J Biol Chem       Date:  2014-12-12       Impact factor: 5.157

Review 4.  Unmasking targets of antitumor immunity via high-throughput antigen profiling.

Authors:  Sebastiano Battaglia; Jason B Muhitch
Journal:  Curr Opin Biotechnol       Date:  2016-03-21       Impact factor: 9.740

5.  Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.

Authors:  Marijana Rucevic; Georgio Kourjian; Julie Boucau; Renata Blatnik; Wilfredo Garcia Bertran; Matthew J Berberich; Bruce D Walker; Angelika B Riemer; Sylvie Le Gall
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

6.  Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms.

Authors:  Guillaume B Stewart-Jones; Peter Simpson; P Anton van der Merwe; Philippa Easterbrook; Andrew J McMichael; Sarah L Rowland-Jones; E Yvonne Jones; Geraldine M Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-16       Impact factor: 11.205

7.  Peptide length determines the outcome of TCR/peptide-MHCI engagement.

Authors:  Julia Ekeruche-Makinde; John J Miles; Hugo A van den Berg; Ania Skowera; David K Cole; Garry Dolton; Andrea J A Schauenburg; Mai Ping Tan; Johanne M Pentier; Sian Llewellyn-Lacey; Kim M Miles; Anna M Bulek; Mathew Clement; Tamsin Williams; Andrew Trimby; Mick Bailey; Pierre Rizkallah; Jamie Rossjohn; Mark Peakman; David A Price; Scott R Burrows; Andrew K Sewell; Linda Wooldridge
Journal:  Blood       Date:  2012-12-18       Impact factor: 22.113

8.  Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability.

Authors:  Kim M Miles; John J Miles; Florian Madura; Andrew K Sewell; David K Cole
Journal:  Mol Immunol       Date:  2010-12-04       Impact factor: 4.407

Review 9.  Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.

Authors:  Etienne Caron; Daniel J Kowalewski; Ching Chiek Koh; Theo Sturm; Heiko Schuster; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2015-12       Impact factor: 5.911

10.  HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV.

Authors:  Clarety Kaseke; Ryan J Park; Nishant K Singh; Dylan Koundakjian; Arman Bashirova; Wilfredo F Garcia Beltran; Overbeck C Takou Mbah; Jiaqi Ma; Fernando Senjobe; Jonathan M Urbach; Anusha Nathan; Elizabeth J Rossin; Rhoda Tano-Menka; Ashok Khatri; Alicja Piechocka-Trocha; Michael T Waring; Michael E Birnbaum; Brian M Baker; Mary Carrington; Bruce D Walker; Gaurav D Gaiha
Journal:  Cell Rep       Date:  2021-07-13       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.